The Boards of Directors of both companies have approved the transaction and Mayne Pharma’s Board of Directors has unanimously recommended that its shareholders vote in favor of the transaction.
Cosette Pharmaceuticals Inc, which is backed by Avista Healthcare Partners and Hamilton Lane, has agreed to acquire Mayne Pharma, an Australian specialty pharmaceutical company, for $430 million.
Mayne Pharma sells products in Australia and the US for birth control and menopause treatments, including its Nextstellis contraceptive pill. Shutterstock Mayne’s shareholders include Viburnum ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results